In his discussion of the fluvoxamine trial, Derek Lowe
concluded, "It's been said before, but it needs to be said several more times: the clinical response to the pandemic, taken has a whole, has not been good, and we're going to have to take steps not to repeat these mistakes if (or when) another such infectious agent appears. That's another topic entirely, but going into what I refer to as Headless Poultry Mode shouldn't be an option. This trial and the ones listed above have been the real beacons in this area, but the US has not exactly been performing up to where it should in this area."